Pancreatic cancer is the fifth most common cause of cancer in the U.S. The majority of patients present with incurable disease, and of those that are candidates for surgical resection by pancreaticoduo-denectomy, few survive five years. In colorectal cancer also, earlier diagnosis would be of great value. The board objective of this proposal is to explore the possibility of practical screening and diagnostic tests for pancreatic and colorectal cancer based on detection of mutant genes in routine clinical samples such as stool, so as to allow earlier diagnosis. Specifically, this study will detect ras gene mutations in such samples, compare results in pancreatic cancer and in colorectal neoplasms, determine whether atypical duct lesions are the precursor of pancreatic cancer and whether they are the source of the cells which enter the gastrointestinal tract, and develop second stage stool assays based on other mutant genes to serve as tests for confirmation of the ras assay results. These studies will include patients with colorectal adenomas and carcinomas, resectable and unresectable pancreatic exocrine adenocarcinoma, benign pancreatic duct disease, chronic pancreatitis, and colorectal adenomas and carcinomas. Three forms of assay are available, and positive results in one will be confirmed using a different system. This study will focus on routine samples such as stool and blood, and will not emphasize invasive and expensive diagnostic samples such as pancreatic secretions and cytologic samples. The methods used to sensitively detect rare mutant DNA sequences in routine specimens will be readily transferable to the more specialized clinical material.
The aim i s to develop clinical tests for general use that will allow a real impact on early diagnosis. Aspects of this study benefit directly from the findings of the companion project 2.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA062924-03S1
Application #
5209333
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Dejea, Christine M; Fathi, Payam; Craig, John M et al. (2018) Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359:592-597
Staedtke, Verena; Bai, Ren-Yuan; Kim, Kibem et al. (2018) Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 564:273-277
Deng, Yang; Tu, Huakang; Pierzynski, Jeanne A et al. (2018) Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer 92:20-32
Tamura, Koji; Yu, Jun; Hata, Tatsuo et al. (2018) Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 115:4767-4772
Chung, Liam; Thiele Orberg, Erik; Geis, Abby L et al. (2018) Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe 23:203-214.e5
Nakamura, Hideki; Lee, Albert A; Afshar, Ali Sobhi et al. (2018) Intracellular production of hydrogels and synthetic RNA granules by multivalent molecular interactions. Nat Mater 17:79-89
Al Efishat, Mohammad A; Attiyeh, Marc A; Eaton, Anne A et al. (2018) Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 268:340-347
Cruz-Correa, Marcia; Hylind, Linda M; Marrero, Jessica Hernandez et al. (2018) Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology 155:668-673
Christmas, Brian J; Rafie, Christine I; Hopkins, Alexander C et al. (2018) Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs. Cancer Immunol Res 6:1561-1577
Blair, Alex B; Murphy, Adrian (2018) Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future. Curr Probl Cancer 42:49-58

Showing the most recent 10 out of 883 publications